These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits. Parkins DA; Taylor AJ Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122 [TBL] [Abstract][Full Text] [Related]
3. Determination of particulate matter in intravenous solutions using the Coulter counter. Blaug SM; Sarabia RE Bull Parenter Drug Assoc; 1975; 29(2):74-88. PubMed ID: 1120215 [No Abstract] [Full Text] [Related]
4. Particulate matter in four reconstituted cephalosporin injections. Kilarski DJ; Visconti JA; Frank SG Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372 [TBL] [Abstract][Full Text] [Related]
5. Particulate matter in parenteral products: a review. Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253 [No Abstract] [Full Text] [Related]
6. [The origin of particulate contamination in injectable solutions]. Lambert G; Moës A J Pharm Belg; 1972; 27(4):402-16. PubMed ID: 4681074 [No Abstract] [Full Text] [Related]
7. Particulate matter in intravenous infusion fluids--phase 3. Turco SJ; Davis NM Am J Hosp Pharm; 1973 Jul; 30(7):611-3. PubMed ID: 4715106 [No Abstract] [Full Text] [Related]
8. Letter: Particulate matter in Ancef and Kefzol. Turco SJ; Davis NM; Bhatia R Am J Hosp Pharm; 1974 Mar; 31(3):222 passim. PubMed ID: 4819435 [No Abstract] [Full Text] [Related]
9. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy. Akers MJ; Schrank GD; Russell S Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911 [TBL] [Abstract][Full Text] [Related]
10. Determination of the particulate content of LVP using different test methods. Health Industry Manufacturer's Association. J Parenter Sci Technol; 1989; 43(5):200-3. PubMed ID: 2809926 [No Abstract] [Full Text] [Related]
11. II. Particulate matter levels in large-volume injections: USP XIX method. Wente MA Bull Parenter Drug Assoc; 1977; 31(4):165-9. PubMed ID: 890179 [No Abstract] [Full Text] [Related]
12. [Contents of admixture of iron in pharmaceutical raw material and injection solutions]. Bugrim NA; Zatula EI Farm Zh; 1970; 25(1):54-6. PubMed ID: 5419006 [No Abstract] [Full Text] [Related]
13. Injectable cephalosporin use in a community teaching hospital. Hazaleus RE; Greenland S; Berdischewsky M Am J Hosp Pharm; 1982 Mar; 39(3):482-3. PubMed ID: 7072737 [No Abstract] [Full Text] [Related]
14. Counting of particulate matter in parenteral solutions. I. Survey of the literature. Lines RW Bull Parenter Drug Assoc; 1967; 21(4):113-7. PubMed ID: 4859718 [No Abstract] [Full Text] [Related]
15. Detection of particulate matter in parenteral solutions by image projection: A concept and its feasibility. Louer RC; Russoman JA; Rasanen PR Bull Parenter Drug Assoc; 1971; 25(2):54-64. PubMed ID: 5563316 [No Abstract] [Full Text] [Related]
16. Letter: Particulate matter in penicillin G potassium injection. Turco SJ; Davis NM; Bhatia R Am J Hosp Pharm; 1974 Sep; 31(9):825-6. PubMed ID: 4420020 [No Abstract] [Full Text] [Related]
17. Non-destructive optical screening method for particulate matter in intravenous solutions. Passl WJ; Rumsey N; Trotter A Analyst; 1980 May; 105(1250):512-5. PubMed ID: 7396221 [No Abstract] [Full Text] [Related]
19. Stability of cefamandole nafate injection with parenteral solutions and additives. Frable RA; Klink PR; Engel GL; Mundell EE Am J Hosp Pharm; 1982 Apr; 39(4):622-7. PubMed ID: 7082453 [No Abstract] [Full Text] [Related]
20. The use of capillary electrophoresis to monitor the stability of a dual-action cephalosporin in solution. Nickerson B; Cunningham B; Scypinski S J Pharm Biomed Anal; 1995 Dec; 14(1-2):73-83. PubMed ID: 8833969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]